|
|
Blood, 15 November 2005, Vol. 106, No. 10, pp. 3423-3431.
Prepublished online as a Blood First Edition Paper on August 2, 2005; DOI 10.1182/blood-2005-04-1388.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways
Ahmad Salameh,
Federico Galvagni,
Monia Bardelli,
Federico Bussolino, and
Salvatore Oliviero
From the Dipartimento di Biologia Molecolare, Università degli Studi di Siena, Italy; Albert Einstein College of Medicine, Bronx, NY; and Istituto per la Cura e la Ricerca sul Cancro and Dipartimento di Scienze Oncologiche, Università di Torino, Candiolo, Torino, Italy.
Vascular endothelial growth factor receptor-3 (VEGFR-3) plays a key role for the remodeling of the primary capillary plexus in the embryo and contributes to angiogenesis and lymphangiogenesis in the adult. However, VEGFR-3 signal transduction pathways remain to be elucidated. Here we investigated VEGFR-3 signaling in primary human umbilical vein endothelial cells (HUVECs) by the systematic mutation of the tyrosine residues potentially involved in VEGFR-3 signaling and identified the tyrosines critical for its function. Y1068 was shown to be essential for the kinase activity of the receptor. Y1063 signals the receptor-mediated survival by recruiting CRKI/II to the activated receptor, inducing a signaling cascade that, via mitogen-activated protein kinase kinase-4 (MKK4), activates c-Jun N-terminal kinase-1/2 (JNK1/2). Inhibition of JNK1/2 function either by specific peptide inhibitor JNKI1 or by RNA interference (RNAi) demonstrated that activation of JNK1/2 is required for a VEGFR-3–dependent prosurvival signaling. Y1230/Y1231 contributes, together with Y1337, to proliferation, migration, and survival of endothelial cells. Phospho-Y1230/Y1231 directly recruits growth factor receptor–bonus protein (GRB2) to the receptor, inducing the activation of both AKT and extracellular signal–related kinase 1/2 (ERK1/2) signaling. Finally, we observed that Y1063 and Y1230/Y1231 signaling converge to induce c-JUN expression, and RNAi experiments demonstrated that c-JUN is required for growth factor–induced prosurvival signaling in primary endothelial cells.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. K. Bajpai, E. Blaskova, S. B. Pakala, T. Zhao, W. C. Glasgow, J. S. Penn, D. A. Johnson, and G. N. Rao
15(S)-HETE Production in Human Retinal Microvascular Endothelial Cells by Hypoxia: Novel Role for MEK1 in 15(S)-HETE Induced Angiogenesis
Invest. Ophthalmol. Vis. Sci.,
November 1, 2007;
48(11):
4930 - 4938.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Wissmann and M. Detmar
Pathways Targeting Tumor Lymphangiogenesis
Clin. Cancer Res.,
December 1, 2006;
12(23):
6865 - 6868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Balsara, F. J. Castellino, and V. A. Ploplis
A Novel Function of Plasminogen Activator Inhibitor-1 in Modulation of the AKT Pathway in Wild-type and Plasminogen Activator Inhibitor-1-deficient Endothelial Cells
J. Biol. Chem.,
August 11, 2006;
281(32):
22527 - 22536.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Young, C. N. Hahn, A. Poh, C. Dong, D. Wilhelm, J. Olsson, G. E. O. Muscat, P. Parsons, J. R. Gamble, and P. Koopman
Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development.
J Natl Cancer Inst,
August 2, 2006;
98(15):
1060 - 1067.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Orlandini, A. Spreafico, M. Bardelli, M. Rocchigiani, A. Salameh, S. Nucciotti, C. Capperucci, B. Frediani, and S. Oliviero
Vascular Endothelial Growth Factor-D Activates VEGFR-3 Expressed in Osteoblasts Inducing Their Differentiation
J. Biol. Chem.,
June 30, 2006;
281(26):
17961 - 17967.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
